Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,645 | -21,394 | -10,882 | -23,571 | -18,761 |
| Depreciation Amortization | -2,054 | -1,653 | -768 | 31 | 620 |
| Accounts receivable | 5,483 | 5,902 | 4,315 | -6,481 | -1,332 |
| Other Working Capital | 1,038 | 1,336 | 3,936 | -3,977 | 621 |
| Other Operating Activity | 5,511 | 1,380 | -925 | 19,215 | 10,156 |
| Operating Cash Flow | $-22,667 | $-14,429 | $-4,324 | $-14,783 | $-8,697 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 61,899 | 58,365 | 31,186 | 266,119 | 18,555 |
| PPE Investments | -2,776 | -2,056 | -1,549 | -290,942 | -16,283 |
| Investing Cash Flow | $59,123 | $56,309 | $29,637 | $-24,823 | $2,272 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,650 | 1,613 | 1,456 | 2,888 | 1,663 |
| Financing Cash Flow | $1,650 | $1,613 | $1,456 | $2,888 | $1,663 |
| Beginning Cash Position | 11,064 | 11,064 | 11,064 | 47,783 | 47,782 |
| End Cash Position | 49,170 | 54,557 | 37,833 | 11,065 | 43,020 |
| Net Cash Flow | $38,106 | $43,493 | $26,769 | $-36,718 | $-4,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,667 | -14,429 | -4,324 | -14,783 | -8,697 |
| Capital Expenditure | -2,785 | -2,065 | -1,558 | -290,942 | -16,283 |
| Free Cash Flow | -25,452 | -16,494 | -5,882 | -305,725 | -24,979 |